FBC
AMGN icon

Fairfield, Bush & Co’s Amgen AMGN Stock Holding History

Fairfield, Bush & Co’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
2,946
-715
-20% -$255K 0.58% 47
2025
Q4 		$1.2M Sell
3,661
-365
-9% -$116K 0.63% 41
2025
Q3 		$1.14M Buy
4,026
+130
+3% +$37.7K 0.58% 43
2025
Q2 		$1.09M Buy
3,896
+230
+6% +$65.2K 0.61% 47
2025
Q1 		$1.14M Sell
3,666
-5
-0.1% -$1.48K 0.72% 43
2024
Q4 		$957K Buy
3,671
+404
+12% +$120K 0.56% 51
2024
Q3 		$1.05M Sell
3,267
-88
-3% -$28.8K 0.63% 45
2024
Q2 		$1.05M Buy
3,355
+443
+15% +$130K 0.63% 44
2024
Q1 		$828K Sell
2,912
-169
-5% -$49.5K 0.49% 52
2023
Q4 		$887K Buy
3,081
+273
+10% +$74.4K 0.52% 49
2023
Q3 		$755K Sell
2,808
-21,422
-88% -$5.35M 0.49% 51
2023
Q2 		$5.38M Buy
24,230
+1,982
+9% +$460K 1.48% 14
2023
Q1 		$5.38M Buy
22,248
+20,367
+1,083% +$5M 1.89% 12
2022
Q4 		$494K Sell
1,881
-489
-21% -$131K 0.33% 65
2022
Q3 		$534K Sell
2,370
-100
-4% -$24.2K 0.38% 59
2022
Q2 		$601K Sell
2,470
-555
-18% -$136K 0.35% 57
2022
Q1 		$732K Sell
3,025
-400
-12% -$91.9K 0.37% 55
2021
Q4 		$771K Sell
3,425
-7,840
-70% -$1.65M 0.37% 57
2021
Q3 		$2.4M Sell
11,265
-12,720
-53% -$2.93M 0.78% 38
2021
Q2 		$5.85M Buy
23,985
+1,250
+5% +$308K 1.59% 15
2021
Q1 		$5.66M Sell
22,735
-450
-2% -$107K 1.61% 12
2020
Q4 		$5.33M Sell
23,185
-210
-0.9% -$48.4K 1.55% 14
2020
Q3 		$5.95M Sell
23,395
-880
-4% -$218K 1.9% 11
2020
Q2 		$5.73M Buy
24,275
+121
+0.5% +$27.6K 2.04% 12
2020
Q1 		$4.9M Buy
24,154
+265
+1% +$57.9K 2.04% 13
2019
Q4 		$5.76M Sell
23,889
-500
-2% -$110K 2.12% 12
2019
Q3 		$4.72M Sell
24,389
-388
-2% -$74.5K 1.63% 17
2019
Q2 		$4.57M Buy
24,777
+100
+0.4% +$17.9K 1.56% 19
2019
Q1 		$5.65M Sell
24,677
-8,255
-25% -$1.58M 1.87% 17
2018
Q4 		$6.41M Sell
32,932
-502
-2% -$97.9K 2.21% 13
2018
Q3 		$6.93M Sell
33,434
-500
-1% -$98.5K 1.95% 12
2018
Q2 		$6.26M Buy
33,934
+260
+0.8% +$46K 1.84% 16
2018
Q1 		$5.74M Sell
33,674
-687
-2% -$126K 1.67% 22
2017
Q4 		$5.97M Buy
34,361
+1,215
+4% +$215K 1.65% 22
2017
Q3 		$6.18M Sell
33,146
-200
-0.6% -$35.4K 1.93% 19
2017
Q2 		$5.74M Hold
33,346
– – 1.84% 21
2017
Q1 		$5.47M Sell
33,346
-600
-2% -$99.7K 1.71% 22
2016
Q4 		$4.96M Buy
33,946
+365
+1% +$54.9K 1.61% 24
2016
Q3 		$5.6M Sell
33,581
-353
-1% -$59.7K 1.81% 20
2016
Q2 		$5.16M Buy
33,934
+150
+0.4% +$23.3K 1.79% 21
2016
Q1 		$5.07M Sell
33,784
-1,435
-4% -$213K 1.81% 21
2015
Q4 		$5.72M Buy
35,219
+30,117
+590% +$4.73M 2% 14
2015
Q3 		$706K Sell
5,102
-28,729
-85% -$4.53M 0.31% 61
2015
Q2 		$5.19M Sell
33,831
-993
-3% -$159K 1.56% 22
2015
Q1 		$5.57M Sell
34,824
-2,635
-7% -$415K 1.62% 19
2014
Q4 		$5.97M Sell
37,459
-1,318
-3% -$205K 1.71% 16
2014
Q3 		$5.45M Sell
38,777
-706
-2% -$92.2K 1.56% 21
2014
Q2 		$4.67M Buy
39,483
+31,262
+380% +$3.62M 1.37% 27
2014
Q1 		$1.01M Sell
8,221
-14
-0.2% -$1.7K 0.48% 41
2013
Q4 		$939K Sell
8,235
-29,337
-78% -$3.34M 0.42% 44
2013
Q3 		$4.21M Sell
37,572
-2,440
-6% -$265K 1.27% 31
2013
Q2 		$3.95M Buy
+40,012
New +$4.15M 2.01% 9

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fairfield, Bush & Co's AMGN Position: Q1 2026 in Review

Fairfield, Bush & Co reduced its Amgen (AMGN) stake by 20% in Q1 2026, selling an estimated $255K and leaving 2,946 shares worth $1.04M. The position accounts for 0.58% of the portfolio, ranked #47.

Fairfield, Bush & Co first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.93M in Q3 2018. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fairfield, Bush & Co held 2,946 shares of Amgen worth $1.04M as of Q1 2026.
  • Fairfield, Bush & Co sold 715 Amgen shares in Q1 2026, an estimated $255K.
  • Amgen made up 0.58% of Fairfield, Bush & Co's portfolio in Q1 2026, its #47 holding.
  • Fairfield, Bush & Co first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Fairfield, Bush & Co's Amgen position peaked at $6.93M in Q3 2018.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.